CLA-B.ST
Cloetta AB (publ) [CLA-B.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLA-B.ST Stock Summary
Top 10 Correlated ETFs
CLA-B.ST
Top 10 Correlated Stocks
CLA-B.ST
In the News
CLA-B.ST Financial details
Company Rating
Strong Buy
Market Cap
5.03B
Income
407M
Revenue
8.02B
Book val./share
18.22
Cash/share
1.09
Dividend
1
Dividend %
5.56%
Employees
2.6K
Optionable
No
Shortable
Yes
Earnings
26 Jan 2024
P/E
12.61
Forward P/E
9.32
PEG
-9.85
P/S
0.63
P/B
0.99
P/C
16.5
P/FCF
14.66
Quick Ratio
0.18
Current Ratio
1.61
Debt / Equity
0.48
LT Debt / Equity
0.45
-
-
EPS (TTM)
1.43
EPS next Y
1.93
EPS next Q
0.51
EPS this Y
-41.46%
EPS next Y
34.97%
EPS next 5Y
34.97%
EPS last 5Y
-10.69%
Revenue last 5Y
2.01%
Revenue Q/Q
7.51%
EPS Q/Q
115.38%
-
-
-
-
SMA20
1.44%
SMA50
0.55%
SMA100
-4.89%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
8%
ROC
0.08%
Gross Margin
32%
Oper. Margin
9%
Profit Margin
5%
Payout
70%
Shs Outstand
290.71M
Shs Float
189.4M
-
-
-
-
Target Price
-
52W Range
17.09-22.82
52W High
-18.27%
52W Low
+5.76%
RSI
43.37
Rel Volume
1.55
Avg Volume
557.39K
Volume
863.01K
Perf Week
-2.55%
Perf Month
3.99%
Perf Quarter
-6.45%
Perf Half Y
-8.31%
-
-
-
-
Beta
0.831
-
-
Volatility
0.14%, 0.24%
Prev Close
-0.72%
Price
17.98
Change
-1.64%
CLA-B.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 21.7 | 22.66 | 19.87 | 21.03 | 23.95 | |
| Net income per share | 1.69 | 1.74 | 0.98 | 1.64 | 0.96 | |
| Operating cash flow per share | 2.19 | 2.53 | 2.29 | 2.98 | 1.81 | |
| Free cash flow per share | 1.55 | 1.88 | 1.28 | 2.31 | 1.06 | |
| Cash per share | 1.92 | 2.02 | 1.38 | 2.41 | 2.03 | |
| Book value per share | 13.85 | 14.65 | 14.58 | 15.71 | 17.41 | |
| Tangible book value per share | -5.79 | -5.19 | -4.83 | -3.71 | -3.1 | |
| Share holders equity per share | 13.85 | 14.65 | 14.58 | 15.71 | 17.41 | |
| Interest debt per share | 9.21 | 9.94 | 8.77 | 8.35 | 8.84 | |
| Market cap | 6.93B | 9.08B | 7.03B | 7.53B | 5.98B | |
| Enterprise value | 8.96B | 11.31B | 9.11B | 9.21B | 7.88B | |
| P/E ratio | 14.35 | 18.24 | 25.01 | 15.96 | 21.76 | |
| Price to sales ratio | 1.12 | 1.4 | 1.23 | 1.25 | 0.87 | |
| POCF ratio | 11.04 | 12.55 | 10.71 | 8.78 | 11.53 | |
| PFCF ratio | 15.62 | 16.89 | 19.2 | 11.34 | 19.62 | |
| P/B Ratio | 1.75 | 2.16 | 1.68 | 1.67 | 1.2 | |
| PTB ratio | 1.75 | 2.16 | 1.68 | 1.67 | 1.2 | |
| EV to sales | 1.44 | 1.74 | 1.6 | 1.52 | 1.15 | |
| Enterprise value over EBITDA | 10.42 | 11.38 | 12.72 | 10.85 | 13.25 | |
| EV to operating cash flow | 14.26 | 15.63 | 13.89 | 10.73 | 15.19 | |
| EV to free cash flow | 20.18 | 21.03 | 24.89 | 13.87 | 25.85 | |
| Earnings yield | 0.07 | 0.05 | 0.04 | 0.06 | 0.05 | |
| Free cash flow yield | 0.06 | 0.06 | 0.05 | 0.09 | 0.05 | |
| Debt to equity | 0.65 | 0.67 | 0.59 | 0.52 | 0.5 | |
| Debt to assets | 0.28 | 0.29 | 0.27 | 0.25 | 0.24 | |
| Net debt to EBITDA | 2.35 | 2.24 | 2.91 | 1.97 | 3.19 | |
| Current ratio | 1.11 | 0.75 | 0.58 | 1.56 | 1.63 | |
| Interest coverage | 10.65 | 18.64 | 13.2 | 17.12 | 6.4 | |
| Income quality | 0.95 | 1 | 1.42 | 1.52 | 1.11 | |
| Dividend Yield | 0.06 | 0.03 | 0.02 | 0.03 | 0.05 | |
| Payout ratio | 0.9 | 0.58 | 0.51 | 0.46 | 1.04 | |
| Sales general and administrative to revenue | 0.1 | 0.1 | 0.1 | 0.11 | 0.1 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.61 | 0.59 | 0.6 | 0.58 | 0.57 | |
| Capex to operating cash flow | -0.29 | -0.26 | -0.44 | -0.23 | -0.41 | |
| Capex to revenue | -0.03 | -0.03 | -0.05 | -0.03 | -0.03 | |
| Capex to depreciation | -0.8 | -0.62 | -1.05 | -0.75 | -0.82 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 22.92 | 23.93 | 17.94 | 24.09 | 19.38 | |
| ROIC | 0.09 | 0.08 | 0.05 | 0.07 | 0.03 | |
| Return on tangible assets | 0.14 | 0.13 | 0.08 | 0.12 | 0.06 | |
| Graham Net | -14.89 | -15.49 | -14.68 | -13.64 | -14.62 | |
| Working capital | 222M | -813M | -1.5B | 838M | 1.07B | |
| Tangible asset value | -1.66B | -1.49B | -1.38B | -1.07B | -889M | |
| Net current asset value | -3.04B | -3.06B | -2.97B | -2.69B | -2.54B | |
| Invested capital | 0.65 | 0.67 | 0.59 | 0.52 | 0.5 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 632M | 518M | 483M | 497M | 550.5M | |
| Average inventory | 755M | 826.5M | 920M | 897.5M | 966.5M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 50.47 | 43.67 | 46.53 | 48.69 | 44.76 | |
| Days of inventory on hand | 70.98 | 78.82 | 93.46 | 78.94 | 83.97 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 7.23 | 8.36 | 7.84 | 7.5 | 8.15 | |
| Inventory turnover | 5.14 | 4.63 | 3.91 | 4.62 | 4.35 | |
| ROE | 0.12 | 0.12 | 0.07 | 0.1 | 0.06 | |
| Capex per share | -0.64 | -0.65 | -1.01 | -0.67 | -0.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 6.26 | 6.64 | 6.91 | 7 | 7.53 | |
| Net income per share | 0.45 | 0.38 | 0.23 | 0.26 | 0.56 | |
| Operating cash flow per share | 1.01 | 0.98 | 0.08 | 0.29 | 0.68 | |
| Free cash flow per share | 0.78 | 0.84 | -0.08 | 0.01 | 0.43 | |
| Cash per share | 1.3 | 2.03 | 1.67 | 0.48 | 1.09 | |
| Book value per share | 16.73 | 17.4 | 17.96 | 18.04 | 18.22 | |
| Tangible book value per share | 16.73 | -3.1 | 17.96 | 18.04 | 18.22 | |
| Share holders equity per share | 16.73 | 17.4 | 17.96 | 18.04 | 18.22 | |
| Interest debt per share | 8.49 | 8.74 | 8.88 | 9.14 | 9.02 | |
| Market cap | 5.05B | 5.99B | 6.24B | 5.6B | 5.21B | |
| Enterprise value | 7.11B | 7.89B | 8.27B | 8.03B | 7.42B | |
| P/E ratio | 9.72 | 13.86 | 24.02 | 19.17 | 8.09 | |
| Price to sales ratio | 2.81 | 3.14 | 3.17 | 2.8 | 2.43 | |
| POCF ratio | 17.49 | 21.31 | 260.19 | 67.43 | 27 | |
| PFCF ratio | 22.67 | 24.84 | -271.51 | 2.8K | 42.37 | |
| P/B Ratio | 1.05 | 1.2 | 1.22 | 1.09 | 1 | |
| PTB ratio | 1.05 | 1.2 | 1.22 | 1.09 | 1 | |
| EV to sales | 3.95 | 4.14 | 4.19 | 4.02 | 3.46 | |
| Enterprise value over EBITDA | 52.66 | 47.24 | 68.91 | 63.2 | 25.86 | |
| EV to operating cash flow | 24.6 | 28.07 | 344.57 | 96.71 | 38.46 | |
| EV to free cash flow | 31.88 | 32.73 | -359.55 | 4.01K | 60.35 | |
| Earnings yield | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | |
| Free cash flow yield | 0.04 | 0.04 | 0 | 0 | 0.02 | |
| Debt to equity | 0.51 | 0.5 | 0.49 | 0.5 | 0.48 | |
| Debt to assets | 0.24 | 0.24 | 0.23 | 0.24 | 0.23 | |
| Net debt to EBITDA | 15.21 | 11.38 | 16.88 | 19.13 | 7.7 | |
| Current ratio | 1.55 | 1.63 | 1.61 | 1.52 | 1.61 | |
| Interest coverage | 16.91 | 7.48 | 5.93 | 4.33 | 3.87 | |
| Income quality | 2.22 | 2.6 | 0.37 | 0.37 | 0.93 | |
| Dividend Yield | 0 | 0 | 0 | 0.05 | 0 | |
| Payout ratio | 0 | 0 | 0 | 3.9 | 0 | |
| Sales general and administrative to revenue | 0.08 | 0.09 | 0.09 | 0.1 | 0.08 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.57 | 0.57 | 0.55 | 0.56 | 0.55 | |
| Capex to operating cash flow | -0.23 | -0.14 | -1.96 | -0.98 | -0.36 | |
| Capex to revenue | -0.04 | -0.02 | -0.02 | -0.04 | -0.03 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 13.06 | 12.14 | 9.59 | 10.19 | 15.21 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Return on tangible assets | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | |
| Graham Net | -15.35 | -14.61 | -15.64 | -16.99 | -16.31 | |
| Working capital | 971M | 1.07B | 1.18B | 1.03B | 1.18B | |
| Tangible asset value | -1B | -889M | -812M | -972M | -820M | |
| Net current asset value | -2.62B | -2.54B | -2.49B | -2.77B | -2.56B | |
| Invested capital | 0.51 | 0.5 | 0.49 | 0.5 | 0.48 | |
| Average receivables | 26.5M | 16M | 16M | 33.5M | 33.5M | |
| Average payables | 0 | 290.5M | 290.5M | 0 | 0 | |
| Average inventory | 1.11B | 1.09B | 1.19B | 1.39B | 1.44B | |
| Days sales outstanding | 1.6 | 0 | 1.46 | 1.58 | 1.34 | |
| Days payables outstanding | 0 | 41.6 | 0 | 0 | 0 | |
| Days of inventory on hand | 79.51 | 78.04 | 85.28 | 99.74 | 80.79 | |
| Receivables turnover | 56.19 | 0 | 61.66 | 57.09 | 67.13 | |
| Payables turnover | 0 | 2.16 | 0 | 0 | 0 | |
| Inventory turnover | 1.13 | 1.15 | 1.06 | 0.9 | 1.11 | |
| ROE | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | |
| Capex per share | -0.23 | -0.14 | -0.16 | -0.28 | -0.25 |
CLA-B.ST Frequently Asked Questions
What is Cloetta AB (publ) stock symbol ?
Cloetta AB (publ) is a SE stock and trading under the symbol CLA-B.ST
What is Cloetta AB (publ) stock quote today ?
Cloetta AB (publ) stock price is $17.98 today.
Is Cloetta AB (publ) stock public?
Yes, Cloetta AB (publ) is a publicly traded company.
Company Profile
- Volume Average 557.39K
- Market Capitalization 5.03B
- Employee 2.6K
- CEO Mr. Henri de Sauvage-Nolting
- Headquarters Sundbyberg,SE
- IPO Date 2000-01-03
-
Website
https://www.cloetta.com 
Cloetta AB (publ) operates as a confectionary company. It manufactures and markets chocolate confectionery products, including pralines, chocolate wafers, dragees, plates, and countlines under the Kexchoklad, Polly, Center, Plopp, Tupla, Royal, Sportlunch, Bridge, Lonka, Sinas, Snippers, and Lonka soft nougat brands. The company also provides confectionery products comprising foams, wine gums, liquorice, toffees, hard boiled candies, and lollypops under the Malaco, Red Band, Ahlgrens bilar, Venco, Chewits, and Juleskum brands. In addition, it offers pastilles under the Läkerol, Mynthon, and King brands, as well as chewing gums under the Jenkki, Sportlife, and Xylifresh brands. Further, the company produces and sells dry roasted nuts under the Nutisal brand. It sells its products through a network of grocery retail trade, service trade, e-commerce, and other sales channels. Cloetta AB (publ) was founded in 1862 and is headquartered in Sundbyberg, Sweden.
